14-74863153-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001243007.2(PROX2):āc.682A>Gā(p.Lys228Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000318 in 1,614,044 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001243007.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROX2 | NM_001243007.2 | c.682A>G | p.Lys228Glu | missense_variant | 3/6 | ENST00000556489.4 | NP_001229936.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROX2 | ENST00000556489.4 | c.682A>G | p.Lys228Glu | missense_variant | 3/6 | 1 | NM_001243007.2 | ENSP00000451223.2 | ||
PROX2 | ENST00000673765.1 | c.682A>G | p.Lys228Glu | missense_variant | 3/5 | ENSP00000501015.1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152214Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000213 AC: 53AN: 249168Hom.: 0 AF XY: 0.000244 AC XY: 33AN XY: 135172
GnomAD4 exome AF: 0.000318 AC: 465AN: 1461712Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 215AN XY: 727138
GnomAD4 genome AF: 0.000315 AC: 48AN: 152332Hom.: 1 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.682A>G (p.K228E) alteration is located in exon 1 (coding exon 1) of the PROX2 gene. This alteration results from a A to G substitution at nucleotide position 682, causing the lysine (K) at amino acid position 228 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at